Shlomi Schwartzblat

Keren Medical Ltd. develops medical technologies for urological applications. It offers urology and surgery products. The company was founded by Jack Baniel, Eyal Bressler, Dan Sade-Hochstadter, Ofer Yossepiwitch and Eliahu Eliachar in 2007 and is headquartered in Jerusalem, Israel.

Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel.

OptiCul Diagnostics, Inc. engages in the medical device company. Its product is optidet that can identify microorganisms immediately from primary culture plate, at the clinical lab, within minutes after applying the sample on the disposable/removable unit. The company is headquartered in Rockville, MD.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

Bonfix Ltd. develops orthopedic implant to treat deformities. It engages in the development of an orthopedic implant to treat deformities related to Hallux Valgus (Bunions). The Bonfix implant offers a minimally invasive procedure to realign the 1st and 2nd metatarsals. The company was founded by Dror Robinsonin 2009 and is headquartered in Jerusalem, Israel.

OptiCul Diagnostics, Inc. engages in the medical device company. Its product is optidet that can identify microorganisms immediately from primary culture plate, at the clinical lab, within minutes after applying the sample on the disposable/removable unit. The company is headquartered in Rockville, MD.

OptiCul Diagnostics, Inc. engages in the medical device company. Its product is optidet that can identify microorganisms immediately from primary culture plate, at the clinical lab, within minutes after applying the sample on the disposable/removable unit. The company is headquartered in Rockville, MD.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

OptiCul Diagnostics, Inc. engages in the medical device company. Its product is optidet that can identify microorganisms immediately from primary culture plate, at the clinical lab, within minutes after applying the sample on the disposable/removable unit. The company is headquartered in Rockville, MD.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel.

Keren Medical Ltd. develops medical technologies for urological applications. It offers urology and surgery products. The company was founded by Jack Baniel, Eyal Bressler, Dan Sade-Hochstadter, Ofer Yossepiwitch and Eliahu Eliachar in 2007 and is headquartered in Jerusalem, Israel.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

Laryngoport Ltd. develops next generation platforms for laryngeal microsurgical procedures. Its tissue handling reduces the dental trauma and tissue damage produced by conventional rigid surgical tools and reduces time spent on positioning and exposure. The company was founded by Moshe Hain and Yonatan Lahav in 2012 and is headquartered in Jerusalem, Israel.

Laryngoport Ltd. develops next generation platforms for laryngeal microsurgical procedures. Its tissue handling reduces the dental trauma and tissue damage produced by conventional rigid surgical tools and reduces time spent on positioning and exposure. The company was founded by Moshe Hain and Yonatan Lahav in 2012 and is headquartered in Jerusalem, Israel.